Graft vs Leukemia Effect

Known as: Effects, Graft-vs-Leukemia, Response, Graft-vs-Leukemia, Graft-vs-Leukemia Responses 
an advantageous side-effect of a graft-vs-host reaction in which a leukemia patient is first irradiated to kill residual leukemic cells and is then… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Regulatory T cells (Tregs) suppress graft-versus-host disease (GVHD) while preserving a beneficial graft-versus-leukemia (GVL… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2008
Review
2008
Allogeneic transplantation of hematopoietic cells is an effective treatment of leukemia, even in advanced stages. Allogeneic… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • table 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Much of the efficacy of allogeneic hematopoietic stem cell transplantation (alloSCT) in curing hematologic malignancies is due to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Graft-versus-leukemia (GVL) response after allogeneic bone marrow transplantation (BMT) represents one of the most potent forms… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Male recipients of transplants from female (F-->M) hematopoietic stem cell donors represent a special group in whom donor T cells… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Acute graft-versus-host disease (GVHD) and leukemic relapse remain the two major obstacles to successful outcomes after… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The major obstacles to successful outcome after allogeneic bone marrow transplantation (BMT) for leukemia remain graft-versus… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based preparative regimen to produce sufficient… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Infusions of large numbers (> 10(8)/kg) of donor leukocytes can induce remissions in patients with chronic myeloid leukemia (CML… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?